Relmada Therapeutics Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market – PRNewswire / Cdn Warrant News, Common Stock Warrants / By https://commonstockwarrants.com Relmada Therapeutics Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market PRNewswire